Alveolar Soft Part Sarcoma

Search Trials
Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma
Status:
Completed
Last Changed:
Sep 24, 2012
First Changed:
Jan 27, 2003
Disease(s):
Sarcoma
Intervention(s):
ifosfamidepegylated liposomal doxorubicin hydrochloride
Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma
Status:
Unknown status
Last Changed:
Aug 8, 2014
First Changed:
Dec 13, 2006
Disease(s):
Ovarian Cancer
Intervention(s):
brostallicindoxorubicin hydrochloride
Randomised Trial of Volume of Post-operative Radiotherapy Given to Adult Patients With eXtremity Soft Tissue Sarcoma
Status:
Completed
Last Changed:
Mar 18, 2021
First Changed:
Jan 18, 2007
Disease(s):
Sarcoma
Intervention(s):
radiotherapy
Sunitinib or Cediranib for Alveolar Soft Part Sarcoma
Status:
Active, not recruiting
Last Changed:
Jun 10, 2022
First Changed:
Jul 12, 2011
Disease(s):
Sarcoma, Alveolar Soft Part
Intervention(s):
CediranibSunitinib
Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma
Status:
Active, not recruiting
Last Changed:
Mar 22, 2022
First Changed:
Jul 21, 2009
Disease(s):
Sarcoma, Alveolar Soft Part
Intervention(s):
AZD2171

Connect. Empower. Inspire.